Discontinued Operations - Summary of Discontinued Operations in Consolidated Statements of Income (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	$ 12,320	$ 0	$ 12,320	$ 0
Cost of sales	292	0	292	0
Gross Profit	12,028	0	12,028	0
Other income (expense):
Discontinued operations, net	$ 0	$ 0	1,534,479	$ 0
AxoBio [Member]
Operating expenses:
Selling and marketing			100,000
Research and development			89,972
General and administrative			470,686
Depreciation and amortization			636,449
Total operating expenses			1,297,107
Loss from operations			(1,297,107)
Other income (expense):
Amortization of debt discount			(4,242)
Total other (expense) income			(111,261)
Loss before income taxes			(1,408,368)
Income tax benefit, deferred			156,092
Discontinued operations, net			$ (1,252,276)
Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]			Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Related Party [Member] | AxoBio [Member]
Other income (expense):
Interest expense			$ (89,448)
Nonrelated Party [Member] | AxoBio [Member]
Other income (expense):
Interest expense			$ (17,571)